TY - JOUR T1 -提升呼吸困难隐形:COVID-19口罩，呼吸不适的体验，改善肺部健康感知-法国全国性调查摩根富林明-欧洲呼吸杂志》乔和J - 10.1183/13993003.01459 -2021欧元SP - 2101459 AU Serresse Laure AU - Simon-Tillaux Noemie盟——Decavele Maxens盟——同性恋,弗雷德里克盟——叉子,娜塔莉盟——Lavault苏菲盟——Guerder安东尼盟——小城堡,安东尼盟——Dabi Frederic AU - Demoule亚历山大盟——Morelot-Panzini卡普辛盟——Moricot卡罗琳盟——Similowski托马斯Y1 - 2021/01/01 UR - //www.qdcxjkg.com/content/early/2021/08/12/13993003.01459 - 2021. -抽象N2 -问题解决与疼痛,呼吸困难是不可见的公众缺乏相应的经验的行李。我们测试了以下假设，即普遍使用口罩抗击SARS-CoV2传播可能改变这种情况，并使人们对呼吸道健康敏感。方法一般人口调查(1012人小组，法国成人人口的人口学代表-定额抽样法;517名女性,51%)。860人(85%)对"因慢性呼吸道疾病接受治疗"("呼吸道健康"，RH)回答"否"，152人回答"是"("呼吸道疾病"，RD)。14%的RH应答者报告有亲密家庭成员因慢性呼吸道疾病接受治疗(RH-family+和RH-family -)。受访者描述了与口罩相关的态度、信仰、不便、呼吸困难和呼吸健康视力的变化。结果口罩依从性高(94.7%)。呼吸困难在口罩带来的不便中排名第一(RD 79.3%， RH 67.3%， p=0.013)。 “Air hunger” was the main sensory dyspnoea descriptor. Mask-related dyspnoea was independently associated with belonging to RH-family+ (Odds Ratio [OR] [95% confidence interval (CI)]: 1.85 [1.16–2.98]) and removing masks to improve breathing (OR 5.21 [3.73–7.28]). It was negatively associated with considering masks effective to protect others (OR]: 0.42 [0.25–0.75]). Half the respondents were more concerned with their respiratory health since wearing masks; 41% reported better understanding patients’ experiences.Answer to the question Wearing protective face masks leads to the mass discovery of breathing discomfort. It raises the public's awareness of what respiratory diseases involve and sensitises to the importance of breathing. These data should be used as the fulcrum of respiratory-health-oriented communication actions.FootnotesThis manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.Conflict of interest: Dr. SERRESSE has nothing to disclose.Conflict of interest: Dr. Simon-Tillaux has nothing to disclose.Conflict of interest: Dr. Decavèle has nothing to disclose.Conflict of interest: Dr. GAY has nothing to disclose.Conflict of interest: Dr. NION has nothing to disclose.Conflict of interest: Dr. Lavault has nothing to disclose.Conflict of interest: Dr. GUERDER has nothing to disclose.Conflict of interest: Mr. CHATELET reports being an employee from the IFOP polling institute, during the conduct of the study.Conflict of interest: Mr. DABI reports being an employee from the IFOP polling institute, during the conduct of the study; .Conflict of interest: Dr. Demoule reports grants, personal fees and non-financial support from Philips, personal fees from Baxter, personal fees and non-financial support from Fisher & Paykel, grants from French Ministry of Health, personal fees from Getinge, grants, personal fees and non-financial support from Respinor, grants, personal fees and non-financial support from Lungpacer, personal fees from Lowenstein, personal fees from Gilead, outside the submitted work; .Conflict of interest: Dr. Morélot-Panzini reports personal fees from Astra-Zeneca, GSK, SOS Oxygène, ADEP, ISIS, Resmed, Chiesi, Menarini, Vivisol, Air Liquide, Lowenstein, Fisher & Paykel, outside the submitted work; .Conflict of interest: Dr. MORICOT has nothing to disclose.Conflict of interest: Dr. SIMILOWSKI reports personal fees from AstraZeneca France, personal fees from Boerhinger Ingelheim France, personal fees and non-financial support from Novartis France, personal fees from TEVA France, personal fees from Chiesi France, personal fees from Lungpacer Inc, personal fees from ADEP Assistance, grants from Air Liquide Medical Systems, outside the submitted work; . ER -